OMERS Growth Equity and Kaiser Permanente led a $153m series E funding round in Evidation Health.

OMERS Growth Equity, a growth investment firm, and Kaiser Permanente, an American integrated managed care consortium, led a $153m series E funding round in Evidation Health, a health tracking platform, with participation from McKesson Ventures and B Capital Group. “Achievement has made it possible to rapidly understand health and therapeutic impact with speed and rigor at scale. The next era of Evidation will transform how individuals interact with the ecosystem of care, by providing anyone with evidence-supported guidance and actionable tools to better understand and improve their health. We are now the first company that can help digital health and biopharma companies generate evidence about their treatments, and then enable individuals to use that evidence to take actions to manage their health,” Deborah Kilpatrick, Evidation CEO.